SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-24-020696
Filing Date
2024-05-20
Accepted
2024-05-20 16:20:37
Documents
7
Effectiveness Date
2024-05-20

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 88268
2 ex5-1.htm EX-5.1 11487
3 ex23-1.htm EX-23.1 3889
4 ex99-1.htm EX-99.1 63535
5 ex99-2.htm EX-99.2 62457
6 ex107.htm EX-FILING FEES 14039
7 ex5-1_001.jpg GRAPHIC 2798
  Complete submission text file 0001493152-24-020696.txt   248810
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279545 | Film No.: 24964795
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)